PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 12934647-3 2003 Salicylate inhibited the IL-1beta and TNF-alpha-induced COX-2 expressions, regulated the activation of ERK, IKK and IkappaB degradation, and the subsequent activation of NF-kappaB, in neonatal rat ventricular cardiomyocytes. Salicylates 0-10 prostaglandin-endoperoxide synthase 2 Rattus norvegicus 56-61 12934647-9 2003 The results showed that salicylate inhibited the activation of ERK and IKK, IkappaB degradation and NF-kappaB activation, independently of the release of ROS, which suggested that salicylate exerts its anti-inflammatory action through the inhibition of ERK, IKK, IkappaB and NF-kappaB, and the resultant COX-2 expression pathway in neonatal rat ventricular cardiomyocytes. Salicylates 24-34 prostaglandin-endoperoxide synthase 2 Rattus norvegicus 304-309 12934647-9 2003 The results showed that salicylate inhibited the activation of ERK and IKK, IkappaB degradation and NF-kappaB activation, independently of the release of ROS, which suggested that salicylate exerts its anti-inflammatory action through the inhibition of ERK, IKK, IkappaB and NF-kappaB, and the resultant COX-2 expression pathway in neonatal rat ventricular cardiomyocytes. Salicylates 180-190 prostaglandin-endoperoxide synthase 2 Rattus norvegicus 304-309 11755167-7 2002 The precise mechanism of the functional antagonism between extremely low doses of salicylate and selective cyclooxygenase-2 inhibitors remains to be investigated. Salicylates 82-92 prostaglandin-endoperoxide synthase 2 Rattus norvegicus 107-123